
IndraLab
Statements
reach
"Additionally, preclinical studies have shown that KRAS siRNA-engineered iExosomes decrease KRAS expression in mice, leading to suppressed cancer cell proliferation, enhanced apoptosis, inhibited metastasis, and increased overall survival without causing cytotoxic effects (Mendt et al., 2018; Kamerkar et al., 2017)."
reach
"23 However, the KRAS variant is associated with a BRCA1 mutation like gene expression signature, supporting the notion that there might be increased oncogenic risk in the presence of the KRAS variant and high KRAS expression and low BRCA1 expression, either through mutation or other mechanisms."
reach
"Oncogenic mutations in KRAS typically occur at hotspots in the protein (e.g., codons 12, 13, and 61), increasing the steady-state levels of KRAS proteins in the GTP-bound state that are capable of driving protumorigenic signaling through downstream effector pathways, such as the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) pathways."
reach
"Taking up liposome‐EV‐KRAS led to much higher KRAS expression in PKH26 lung cells (67.0%) (Figure S4b) compared with KRAS (0.01%) expressed in the lung cells of mice treated with free PKH26 dye.2.3
EV G12D-mutant KRAS complex induces lung inflammation via Fn1 mediated induction of IL-17A."
reach
"These data indicated that upregulated H3 K27M might be a potent treatment target for diffuse midline glioma, H3 K27M-mutant exhibiting MASI of H3F3A K27M.There were previous studies where KRAS MASI elevated KRAS mRNA levels, increasing RAS activity [14, 24] and wild-type allele of KRAS has also been shown to play a pivotal role as a tumor suppressor [25]."
reach
"In studies of adult mouse pancreas, expression of Kras from the endogenous Kras locus does not lead to carcinoma unless a tumor suppressor such as Trp53 and/or Fbw7 is also mutated.7, 8, 9 However, with Kras expression in ducts, CP led to neoplastic changes including carcinoma in situ by 2 months."
reach
"Based on these results we hypothesized that CRNDE/hnRNPA2B1 axis promoted KRAS protein expression by translational control of KRAS mRNA.To gain further insight into its mechanism, the SUnSET assays were employed, and the results unveiled that hnRNPA2B1 strongly influenced global protein synthesis (Fig. 6J, S7B)."
reach
"KRAS protein functions as a molecular switch cycling between ON and OFF state to affect the intracellular signaling.30 Whereas the ON switch to the active state is promoted by guanine nucleotide exchange factors (GEFs), the OFF state is regulated by GTPase-activating proteins (GAPs).33 Oncogenic alleles of KRAS lose the capability of GAP-induced GTP hydrolysis resulting in increased GTP-bound KRAS protein levels which in turn trigger the pro-growth signaling pathways."